Bladder Invasive Urothelial Carcinoma PD-L1 (SP263) Immunohistochemical Detection Consensus

NMIBC recurrent transurethral Laser Ablation

NMIBC chemotherapy intravesical

NMIBC chemotherapy hyperthermia

Adult Embolization Therapeutic/*adverse effects/methods Humans Lower Urinary Tract Symptoms/*etiology Male Middle Aged Patient Reported Outcome Measures Penile Erection/physiology Prostate/blood supply Prostatic Hyperplasia/*therapy Randomized Controlled Trials as Topic Safety Treatment Outcome Benign prostatic hyperplasia Lower urinary tract symptoms Prostatic artery embolization Systematic review

Aged Drug Therapy Combination Erectile Dysfunction/*drug therapy Humans Male Middle Aged Phosphodiesterase Inhibitors Prostatic Hyperplasia/*drug therapy Tadalafil Tamsulosin Treatment Outcome Vasodilator Agents *benign prostatic hyperplasia *erectile dysfunction *meta-analysis *tadalafil *tamsulosin conflicts of interest with respect to the research authorship and/or publication of this article.

Photoselective vaporization benign prostate hyperplasia meta-analysis

Oral antithrombotic drugs benign prostate hyperplasia

Anticoagulants Blood Transfusion *Deprescriptions Dysuria/epidemiology Humans Laser Therapy Male Operative Time Postoperative Complications/epidemiology Prostatic Hyperplasia Reoperation Transurethral Resection of Prostate Urethral Stricture/epidemiology Urinary Tract Infections/epidemiology Anticoagulant Benign prostate hyperplasia (BPH) Lower urinary tract symptom (LUTS) Photoselective vaporization (PVP)

Administration Oral Fibrinolytic Agents/*administration & dosage Humans Lasers Solid-State Male Prostatic Hyperplasia Risk Factors Antithrombotic Benign prostate hyperplasia (BPH) Holmium laser enucleation of the prostate (HoLEP) Perioperative safety

Aged Catheterization Humans *Laser Therapy Lower Urinary Tract Symptoms/physiopathology Male Prostate/physiopathology Prostatic Hyperplasia/physiopathology Randomized Controlled Trials as Topic *Transurethral Resection of Prostate Treatment Outcome benign prostatic hyperplasia (BPH) button-type bipolar plasma vaporization (BTPV) lower urinary tract symptoms (LUTS) transurethral resection (TURP)

Aged Holmium Humans *Laser Therapy Lasers Solid-State Male Postoperative Complications/etiology Prostate/*radiation effects Prostatic Hyperplasia Publication Bias Randomized Controlled Trials as Topic Thulium Treatment Outcome Efficacy Enucleation Holmium laser Meta-analysis Safety Thulium laser

Benign prostate hyperplasia metabolic syndrome meta-analysis

Aged Humans Lower Urinary Tract Symptoms/*etiology Male Prostatic Hyperplasia Transurethral Resection of Prostate Urethra/physiopathology

Humans Male *Prostatic Hyperplasia

Benign prostatic hyperplasia Bladder fluid Blood loss Hypothermia Irrigation fluid Shiver Temperature

Implantable Nitinol Devices Minimally Invasive Treatments BPH Systematic Review

Androgen Antagonists/*pharmacology Biomarkers/urine Humans Inflammation/urine Lower Urinary Tract Symptoms/physiopathology Male Observational Studies as Topic Phytotherapy Plant Extracts/*pharmacology Prostatic Hyperplasia/physiopathology/urine Randomized Controlled Trials as Topic Serenoa Treatment Outcome * Serenoa repens *Luts/bph *Permixon *hexanic extract *meta-analysis *systematic review

Adrenergic alpha-Antagonists Drug Therapy Combination Humans Lower Urinary Tract Symptoms Male Middle Aged Phosphodiesterase Inhibitors Prostatic Hyperplasia Randomized Controlled Trials as Topic

Antifibrinolytic Agents/*administration & dosage Blood Loss Surgical/*prevention & control Blood Transfusion/statistics & numerical data Humans Incidence Male Prostatectomy/*adverse effects Prostatic Hyperplasia/surgery Prostatic Neoplasms/surgery Thromboembolism/*epidemiology/etiology Tranexamic Acid/*administration & dosage *Anesthesia *Blood loss *Prostate *Review *Surgical *Systematic *Tranexamic acid